EUVIMEDEUVIMED entdecken
Crossref

Stem Cell-Based Interventions for COVID-19: A Systematic Evaluation : Stem Cells

Shadi Mohammadpour-Asl, Forough Shams, Navid Ghasemzadeh, Hossein Maghsoudi, Shahriar Alipour, Mohammad Heidari, Golchin, Ali

The Journal of Applied Tissue Engineering · 10.08.2024

DOI: 10.22034/jate.2024.108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Applied Tissue Engineering, erschienen am 10.08.2024. Verfasst von Shadi Mohammadpour-Asl und 7 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The emergence of the COVID-19 pandemic has prompted an urgent search for effective therapeutic interventions. Mesenchymal stem cell (MSC) therapy has garnered significant attention due to its potential immunomodulatory and regenerative properties. This systematic review aims to evaluate the safety and efficacy of MSC therapy for COVID-19 treatment and introduce the principal aspects of using MSCs as therapeutic agents.

Methods

A systematic search of major databases including PubMed and Scopus, was conducted to identify relevant studies published up to January 2020 and January 2023. Eligible studies were critically appraised for methodological quality, and data on safety outcomes, including adverse events, and efficacy outcomes, such as clinical improvement and mortality rates, were synthesized. Moreover, we searched the clinical trial registry website and extracted detailed information on registered stem cell therapies for COVID-19 patient treatment.

Results

Preliminary findings demonstrate that MSC therapy holds promise as a potential treatment option for severe COVID-19 patients, indicating favorable safety profiles and encouraging clinical outcomes.

Conclusion

However, preliminary findings confirm the helpful impact of MSC therapy for COVID-19, but further well-designed randomized controlled trials are warranted to establish the optimal dosing regimens, the timing of administration, and the long-term effects of MSC therapy in COVID-19 management.

Schlagwörter

COVID-19 pandemicmesenchymal stem cellsstem cell therapyimmunomodulationregenerative therapytreatment safetytreatment efficacyclinical trial registriessevere COVID-19

Zitieren

APA

Mohammadpour-Asl, S., Shams, F., Ghasemzadeh, N., Maghsoudi, H., Alipour, S., Heidari, M., Golchin, & Ali (2024). Stem Cell-Based Interventions for COVID-19: A Systematic Evaluation : Stem Cells. The Journal of Applied Tissue Engineering. https://doi.org/10.22034/jate.2024.108

Vancouver

Mohammadpour-Asl S, Shams F, Ghasemzadeh N, Maghsoudi H, Alipour S, Heidari M, et al. Stem Cell-Based Interventions for COVID-19: A Systematic Evaluation : Stem Cells. The Journal of Applied Tissue Engineering. 2024. doi:10.22034/jate.2024.108

BibTeX
@article{MohammadpourAsl2024,
  author = {Mohammadpour-Asl, Shadi and Shams, Forough and Ghasemzadeh, Navid and Maghsoudi, Hossein and Alipour, Shahriar and Heidari, Mohammad and Golchin and Ali},
  title = {Stem Cell-Based Interventions for COVID-19: A Systematic Evaluation : Stem Cells},
  journal = {The Journal of Applied Tissue Engineering},
  year = {2024},
  doi = {10.22034/jate.2024.108}
}
Kostenlos starten →